Abivax (ABVX) Exchange Rate Effect (2024 - 2026)
Abivax (ABVX) posted quarterly Exchange Rate Effect of $8.7 million for Q1 2026, up 1278.98% year-over-year from $629527.5 in Q1 2025, and up 648.36% quarter-over-quarter from -$1.6 million in Q4 2025.
Abivax (ABVX) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Abivax's Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 1278.98% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $18.3 million (up 4922.42% YoY), while the FY2025 annual figure was -$12.0 million, down 567.5% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $8.7 million, up from -$1.6 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $12.5 million in Q3 2025, with the low at -$2.1 million in Q3 2024.
- The 3-year median for Exchange Rate Effect is $485676.3 (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect sank 352.88% in 2025, then jumped 1278.98% in 2026.
- Abivax's Exchange Rate Effect stood at $2.7 million in 2024, then sank by 157.62% to -$1.6 million in 2025, then soared by 648.36% to $8.7 million in 2026.
- Business Quant data shows ABVX's Exchange Rate Effect at $8.7 million in Q1 2026, -$1.6 million in Q4 2025, and $12.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 8.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | -1.58 Mn |
| Dec 31, 2025 | -1.58 Mn |
| Sep 30, 2025 | 12.47 Mn |
| Sep 30, 2025 | 12.47 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -736,319.11 |
| Mar 31, 2025 | -736,319.11 |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | 485,676.30 |
| Jun 30, 2024 | 485,676.30 |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |